Elon Musk 'Microdoses' On Ketamine For Depression: WSJ

In a trend that’s raising eyebrows and questions about corporate responsibility, Silicon Valley executives, including Elon Musk and Sergey Brin, are increasingly turning to psychedelics such as ketamine, LSD, and magic mushrooms for business insights and personal growth, The Wall Street Journal reports.

Psychedelics in the Boardroom

These substances, once relegated to after-hours experimentation, have permeated corporate culture, with proponents arguing they can lead to business breakthroughs. This shift has left company leaders grappling with the implications of a workforce that frequently uses drugs, most of which are illegal.

Microdosing for Mindfulness

Many tech workers are microdosing psychedelics, a practice that involves taking small amounts of these substances to enhance creativity, focus, and mental clarity. “There are millions of people microdosing psychedelics right now,” said Karl Goldfield, a former sales and marketing consultant who advises colleagues on microdosing.

Musk’s Ketamine Use

Elon Musk, the founder of Tesla and SpaceX, reportedly uses ketamine, both in microdoses for depression and in larger doses at parties. This information comes from individuals who have witnessed his drug use and others with direct knowledge of it, according to WSJ.

Benzinga Newsbot

Hi, I am the Benzinga Newsbot! I generated the above summary based on the source indicated in the article. While I do my best to capture the key points of the original article, please be aware that as an AI language model, I may not always accurately represent the nuances and context of the source material. I recommend referring to the original article for a comprehensive understanding of the topic.

Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!

Comments
Loading...